ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2020 - FDA's Regulation of Regenerative Medicine including Stem Cell Treatments and Tissue Engineering

Date2020-04-30 - 2020-05-01


VenueSan Francisco, CA, USA - United States USA - United States

KeywordsFDA stem cell therapies; HCT/P products; Regenerative Medicine


Topics/Call fo Papers

Stem cells harness the power to differentiate into numerous cells upon stimulation. This has led to their wide exploration across all of medicine, including high risk diseases. Of course, significant scientific breakthroughs in the use of stem cells to prevent, diagnose, and treat numerous diseases has caused numerous start-up companies to form. Despite, such promise, the FDA has yet to approve stem cell therapies for a wide range of diseases, except cord blood-derived hematopoietic progenitor cells for certain indications. Attend this seminar to learn and apply the definitive ways to needed for the field to progress.

Last modified: 2020-02-13 16:19:46